|
Disease Fields |
Product |
Territory Rights |
Indications |
Preclinical Study Clinical Study Approval |
State |
|
Respiratory |
Oselavir® (Oseltamivir Phosphate for Suspension) |
CN |
Anti-influenza |
|
Approved in China
|
|
Beishuqing® (Procaterol Hydrochloride Oral Solution) |
Global |
Asthma & Bronchial Disease |
|
Approved in China
|
|
|
Beishujie® (Procaterol Hydrochloride Inhalation Solution) |
Global |
Asthma & Bronchial Disease |
|
Approved in China
|
|
|
Anti-infection |
Posaconazole Oral Suspension |
CN |
Fungal Infection |
|
Filed (CN)
|
|
Meinuoxian® (Sultamicillin Powder for Oral Suspension) |
Global |
Anti-infection |
|
BE Ongoing (CN)
|
|
|
BM-R06 |
Global |
Anti-infection |
|
Under Development
|
|
|
Gastroenterology |
Presomid® (Esomeprazole Magnesium for Delayed-Release Oral Suspension) |
CN |
NERD & HPs |
|
Approved in China
|
|
BM-R14 |
Global |
Colon Cleansing |
|
Pilot Study (BE Waived)
|
|
|
BM-R13 |
Global |
Acute Poisoning |
|
Under Development
|
|
|
Hematology |
Rifosar® (Sevelamer Carbonate Powder for Oral Suspension) |
CN |
Hyperphosphatemia |
|
Filed (CN)
|
|
BM-L08/L09 |
CN |
Iron Overload |
|
Dossier Ready (CN) (BE Waived)
|
|
|
BM-R09 |
Global |
ALL |
|
Pilot Study
|
|
|
Endocrinology |
Levothyroxine Sodium Oral Solution |
CN |
Hypothyroidism |
|
BE Ongoing (CN)
|
|
Neonatology |
BM-L13 |
CN |
Hemorrhagic Disease |
|
Pre-IND
|
|
Neuroscience |
Lancovul® (Lacosamide Oral Solution) |
CN |
First-line Anti-epileptic |
|
Approved in China
|
|
Beizesi® (Atomoxetine Hydrochloride Oral Solution) |
Global |
ADHD |
|
Approved in China
|
|
|
Desmopressin Acetate Oral Solution |
Global |
Nocturnal Enuresis |
|
Dossier Ready (CN) (BE Waived)
|
|
|
BM-L14 |
CN |
Spasticity |
|
Dossier Ready (CN) (BE Waived)
|
|
|
BM-R19 |
Global |
Schizophrenia |
|
BE Ongoing (CN)
|
|
|
BM-R17 |
Global |
Overactive Bladder |
|
Pilot Study
|
|
|
Dermatology & ENT |
BM-L12 |
CN |
AOE & AOM |
|
IND Application (CN)
|
|
BM-R16 |
Global |
AD |
|
Pilot Study
|
|
|
BM-R15 |
Global |
Acne Vulgaris |
|
Under Development
|
|
|
Immunology |
Bidashu® (Desloratadine Oral Solution) |
Global |
Antiallergy |
|
Approved in China
|
|
BM-R12 |
Global |
Antiallergy |
|
Dossier Ready (CN)
|
